REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ab Roys Pharmaceutical Private Limited (India)

Main Activities: Other Business Support Services
Full name: Ab Roys Pharmaceutical Private Limited Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Ab Roy's Pharmaceutical Private Limited is an unlisted company, incorporated on 20/02/1998. It has its registered office in the State of West Bengal, India. Company's corporate identification number (CIN) is U74999WB1998PTC086604 and registration number is 086604. The company is a trade company, it is engaged in wholesale trading.

Legal Address
2 South Roadsantoshpur
Kolkata; West Bengal; Postal Code: 700075

Contact Details: Purchase the Ab Roys Pharmaceutical Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Ab Roys Pharmaceutical Private Limited report to view the information.
Registered Capital:
Purchase the Ab Roys Pharmaceutical Private Limited report to view the information.
Incorporation Date:
February 20, 1998
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Company Performance
Financial values in the chart are available after Ab Roys Pharmaceutical Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
19.86%▲
Total operating revenue
19.88%▲
Operating profit (EBIT)
-57.27%▼
EBITDA
-56.6%▼
Net Profit (Loss) for the Period
-57.48%▼
Total assets
54.82%▲
Total equity
4.71%▲
Operating Profit Margin (ROS)
-1.19%▼
Net Profit Margin
-0.9%▼
Return on Equity (ROE)
-6.57%▼
Debt to Equity Ratio
34.12%▲
Quick Ratio
-0.2%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo